RDY - Dr. Reddy's Laboratories Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
7.08B
Enterprise Value 3
7.06B
Trailing P/E
30.16
Forward P/E 1
23.93
PEG Ratio (5 yr expected) 1
1.67
Price/Sales (ttm)
N/A
Price/Book (mrq)
3.66
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.20
52-Week Change 312.41%
S&P500 52-Week Change 325.71%
52 Week High 342.91
52 Week Low 334.67
50-Day Moving Average 340.91
200-Day Moving Average 338.65

Share Statistics

Avg Vol (3 month) 3174.73k
Avg Vol (10 day) 3272.44k
Shares Outstanding 5165.77M
Float 120.46M
% Held by Insiders 10.02%
% Held by Institutions 114.55%
Shares Short (Dec 30, 2019) 41.29M
Short Ratio (Dec 30, 2019) 47.53
Short % of Float (Dec 30, 2019) 4N/A
Short % of Shares Outstanding (Dec 30, 2019) 40.78%
Shares Short (prior month Nov 28, 2019) 41.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.29
Trailing Annual Dividend Yield 30.69%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 14, 2019
Ex-Dividend Date 4Jul 12, 2018
Last Split Factor 22:1
Last Split Date 3Sep 06, 2006

Financial Highlights

Currency in INR.

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 16.20%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)6.98%
Return on Equity (ttm)18.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)26.40%
Gross Profit (ttm)83.43B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)1.40
Quarterly Earnings Growth (yoy)116.90%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)20.51
Current Ratio (mrq)1.96
Book Value Per Share (mrq)11.57

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A